STOCK TITAN
  1. Home
  2. Sec-filings
  3. WLKP
  4. [8-K] Westlake Chemical Partners LP Reports Material Event

Net income climbs to $14.2M at Westlake Chemical Partners (WLKP)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Westlake Chemical Partners LP reported sharply improved first quarter 2026 results. Net income attributable to the Partnership rose to $14.2 million, or $0.40 per limited partner unit, compared to $4.9 million, or $0.14 per unit, in first quarter 2025.

Cash flows from operating activities increased to $110.2 million from $45.8 million a year earlier, driven by higher production and sales volume following the prior year's Petro 1 turnaround. MLP distributable cash flow grew to $17.9 million from $4.7 million.

The Partnership declared a quarterly distribution of $0.4714 per unit, its 47th consecutive quarterly distribution, with a first quarter 2026 coverage ratio of 1.08x and trailing twelve‑month coverage of 1.00x, up from 0.82x at the end of fourth quarter 2025.

Positive

  • Substantial year-over-year earnings growth: Net income attributable to the Partnership rose to $14.2 million from $4.9 million in first quarter 2025, supported by higher production and sales volume after the prior year's Petro 1 turnaround.
  • Stronger cash generation and coverage: Operating cash flow increased to $110.2 million from $45.8 million, while MLP distributable cash flow rose to $17.9 million from $4.7 million, lifting trailing twelve‑month distribution coverage to 1.00x from 0.82x.

Negative

  • None.

Insights

Westlake Chemical Partners delivered significantly higher earnings and cash flow with improving distribution coverage.

Westlake Chemical Partners LP showed much stronger profitability in Q1 2026, with net income attributable to the Partnership at $14.2 million versus $4.9 million a year earlier. Operating cash flow rose to $110.2 million, reflecting higher production and sales after the prior Petro 1 turnaround.

MLP distributable cash flow increased to $17.9 million from $4.7 million, supporting a quarterly distribution of $0.4714 per unit. The coverage ratio was 1.08x for Q1 2026 and trailing twelve‑month coverage improved to 1.00x from 0.82x at the end of Q4 2025, indicating better alignment between cash generation and payouts.

Management noted that, late in the quarter, the war with Iran and closure of the Strait of Hormuz led to stronger global demand for North American chemicals and polymers, boosting third‑party ethylene sales prices. Future disclosures in company filings may further clarify how sustained these margin effects and coverage metrics remain.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net income attributable to Partnership $14.2 million First quarter 2026; above $4.9 million in first quarter 2025
Net income per limited partner unit $0.40 per unit First quarter 2026; versus $0.14 per unit in first quarter 2025
Cash flows from operating activities $110.2 million First quarter 2026; compared to $45.8 million in first quarter 2025
MLP distributable cash flow $17.9 million First quarter 2026; compared to $4.7 million in first quarter 2025
Quarterly distribution per unit $0.4714 per unit Declared for first quarter 2026; 47th consecutive quarterly distribution
EBITDA $121.2 million First quarter 2026; versus $75.0 million in first quarter 2025
Total net sales $305.7 million First quarter 2026; $263.1 million from Westlake, $42.6 million from third parties
Trailing twelve-month coverage ratio 1.00x Coverage of declared distributions for first quarter 2026; above 0.82x at end of Q4 2025
MLP distributable cash flow financial
"For the three months ended March 31, 2026, MLP distributable cash flow was $17.9 million..."
A Master Limited Partnership (MLP) distributable cash flow is the amount of cash an MLP generates from its core operations that is available to pay out to investors after covering operating costs, routine upkeep and any required reserves. Think of it like a household’s leftover pay after bills and savings: it shows how much can realistically be distributed to owners and helps investors judge the safety and sustainability of cash payouts and the partnership’s financial health.
coverage ratio financial
"generating a coverage ratio 1.08x for the first quarter of 2026"
EBITDA financial
"These non-GAAP financial measures should be considered as a supplement... such as MLP distributable cash flow, coverage ratio and EBITDA"
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.
noncontrolling interest financial
"Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP"
The portion of a business owned by investors other than the controlling owner when one company has control of another; it represents outside shareholders’ share of the subsidiary’s assets and profits. For investors, it matters because those outside claims reduce the amount of profit and net assets attributable to the parent owner — similar to saying part of a pizza belongs to someone else — and thus affects earnings, book value and valuation.
Investment Management Agreement financial
"Receivable under the Investment Management Agreement—Westlake"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
Ethylene Sales Agreement financial
"OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows"
A ethylene sales agreement is a contract in which a producer promises to sell and a buyer agrees to purchase specified volumes of ethylene, a basic feedstock used to make plastics and chemicals. For investors it matters because these deals shape a company’s predictable revenue, pricing exposure and plant utilization—like a subscription that guarantees sales and helps forecast profits, or a supply lock that shields against market swings.
Net income attributable to Westlake Partners $14.2 million
Net income per limited partner unit $0.40
Cash flows from operating activities $110.2 million
MLP distributable cash flow $17.9 million
EBITDA $121.2 million
Understanding 8-K Material Events →
0001604665false00016046652026-05-052026-05-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 5, 2026

Westlake Chemical Partners LP
(Exact name of registrant as specified in its charter)

Delaware001-3656732-0436529
(State or other jurisdiction
of incorporation)		(Commission File Number)(I.R.S. Employer
Identification No.)
2801 Post Oak Boulevard,Suite 60077056
Houston,Texas
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (713) 585-2900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common units representing limited partnership interestsWLKPThe New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻





Item 2.02. Results of Operations and Financial Condition.
On May 5, 2026, Westlake Chemical Partners LP (the "Partnership") issued a press release announcing its 2026 first quarter results. A copy of the press release is furnished with this Current Report as Exhibit 99.1.
The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing by Westlake Chemical Partners LP under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, unless specifically identified as being incorporated therein.
Item 7.01. Regulation FD Disclosure.
The Partnership is holding a conference call on May 5, 2026 to discuss its 2026 first quarter results. Information about the call can be found in the press release furnished with this Current Report as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are furnished herewith:
99.1    Press release issued on May 5, 2026.
104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WESTLAKE CHEMICAL PARTNERS LP
By: Westlake Chemical Partners GP LLC
Date:May 5, 2026By:
/S/    JEAN-MARC GILSON        
Jean-Marc Gilson
President, Chief Executive Officer and Director






EXHIBIT 99.1
WESTLAKE CHEMICAL PARTNERS LP

Contact—(713) 585-2900
Investors—Steve Bender
Media—L. Benjamin Ederington


Westlake Chemical Partners LP Announces First Quarter 2026 Results
•Declared quarterly distribution of $0.4714 per unit; 47th consecutive quarterly distribution
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the first quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was above first quarter 2025 net income of $4.9 million. Cash flows from operating activities in the first quarter of 2026 were $110.2 million, an increase of $64.4 million compared to first quarter 2025 cash flows from operating activities of $45.8 million, due to higher production and sales volume as the result of the prior year's Petro 1 turnaround. For the three months ended March 31, 2026, MLP distributable cash flow was $17.9 million, an increase of $13.2 million compared to first quarter 2025 MLP distributable cash flow of $4.7 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio was primarily due to higher production and sales volume and lower maintenance capital expenditures as a result of the prior year's Petro 1 turnaround.
Compared to the fourth quarter of 2025, first quarter 2026 net income attributable to the Partnership of $14.2 million decreased by $0.3 million due to seasonally lower production and sales volume. First quarter 2026 cash flows from operating activities of $110.2 million decreased by $10.2 million due to working capital changes. First quarter 2026 MLP distributable cash flow of $17.9 million decreased by $0.9 million compared to fourth quarter 2025 MLP distributable cash flow of $18.8 million due to lower production and sales volume.
"The Partnership began the year with solid production and sales volume, generating a coverage ratio 1.08x for the first quarter of 2026," said Jean-Marc Gilson, President and Chief Executive Officer. "Late in the first quarter, following the outbreak of the war with Iran and the closure of the Strait of Hormuz, global demand for North American chemicals and polymers accelerated meaningfully. This surge in export demand has driven higher third-party ethylene sales prices, which is benefiting the Partnership's distributable cash flow and coverage ratio."
On May 4, 2026, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the first quarter of 2026 of $0.4714 per common unit to be payable on June 1, 2026 to unitholders of record as of May 14, 2026, representing the 47th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage that was 1.00x the declared distributions for the first quarter of 2026, which was above the trailing twelve-month coverage ratio of 0.82x at the end of the fourth quarter of 2025. Since our IPO in July of 2014 our cumulative coverage ratio is approximately 1.05x.
OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.
i
The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the timing and results of our turnaround activities, our outlook for third-party ethylene margins, the impact of the Iran war on global demand for our products, our expectations regarding feedstock and energy costs, the ability to deliver value, returns, predictable cash flows and distributions to unitholders; our relationship with Westlake and the benefits of the ethylene sales agreement, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: operating difficulties or disruptions; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including determinations made pursuant to contractual arrangements with Westlake; the effects of legal proceedings; actions of third parties; inclement or hazardous weather conditions; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; inability of our customers to take delivery; fires, explosions or other industrial accidents; political tension and conflict in the Middle East and elsewhere; the supply/demand balance for our products; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC in March 2026.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.
ii
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' first quarter 2026 results will be held Tuesday, May 5th, 2026 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI15886588e6004070bc18c354348f7575. A dial-in will be provided upon registration.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/493g3eiw and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.
iii

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended March 31,
20262025
(In thousands of dollars, except per unit data)
Revenue
Net sales—Westlake Corporation ("Westlake")$263,091 $190,781 
Net co-products, ethylene and other sales—third parties42,584 46,848 
Total net sales305,675 237,629 
Cost of sales211,916 183,548 
Gross profit93,759 54,081 
Selling, general and administrative expenses7,190 7,474 
Income from operations86,569 46,607 
Other income (expense)
Interest expense—Westlake(5,085)(5,537)
Other income, net348 1,346 
Income before income taxes81,832 42,416 
Provision for income taxes177 107 
Net income81,655 42,309 
Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")67,486 37,361 
Net income attributable to Westlake Partners$14,169 $4,948 
Net income per limited partner unit attributable to Westlake Partners (basic and diluted)
Common units$0.40 $0.14 
Distributions declared per unit$0.4714 $0.4714 
MLP distributable cash flow$17,886 $4,714 
Distributions declared
Limited partner units—publicly and privately held$9,958 $9,954 
Limited partner units—Westlake6,657 6,657 
Total distributions declared$16,615 $16,611 
EBITDA$121,216 $75,021 

iv

WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
March 31,
2026		December 31,
2025
(In thousands of dollars)
ASSETS
Current assets
Cash and cash equivalents$44,290 $44,269 
Receivable under the Investment Management Agreement—Westlake36,441 23,378 
Accounts receivable, net—Westlake45,082 63,571 
Accounts receivable, net—third parties19,778 9,113 
Inventories3,093 2,769 
Prepaid expenses and other current assets219 406 
Total current assets148,903 143,506 
Property, plant and equipment, net871,606 886,012 
Other assets, net215,189 227,015 
Total assets$1,235,698 $1,256,533 
LIABILITIES AND EQUITY
Current liabilities (accounts payable and accrued and other liabilities)$40,792 $51,301 
Long-term debt payable to Westlake399,674 399,674 
Other liabilities2,846 3,206 
Total liabilities443,312 454,181 
Common unitholders—publicly and privately held459,382 460,848 
Common unitholder—Westlake39,280 40,260 
General partner—Westlake(242,572)(242,572)
Total Westlake Partners partners' capital256,090 258,536 
Noncontrolling interest in OpCo536,296 543,816 
Total equity792,386 802,352 
Total liabilities and equity$1,235,698 $1,256,533 
v

WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended March 31,
20262025
(In thousands of dollars)
Cash flows from operating activities
Net income$81,655 $42,309 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization34,299 27,068 
Net loss on disposition and other131 240 
Other balance sheet changes(5,887)(23,836)
Net cash provided by operating activities110,198 45,781 
Cash flows from investing activities
Additions to property, plant and equipment(5,556)(15,956)
Investments with Westlake under the Investment Management Agreement(13,000)— 
Maturities of investments with Westlake under the Investment Management Agreement— 30,000 
Net cash provided by (used for) investing activities
(18,556)14,044 
Cash flows from financing activities
Proceeds from debt payable to Westlake40,500 54,000 
Repayment of debt payable to Westlake(40,500)(54,000)
Distributions to noncontrolling interest retained in OpCo by Westlake(75,006)(51,906)
Distributions to unitholders(16,615)(16,611)
Net cash used for financing activities(91,621)(68,517)
Net increase (decrease) in cash and cash equivalents
21 (8,692)
Cash and cash equivalents at beginning of period44,269 58,316 
Cash and cash equivalents at end of period$44,290 $49,624 

vi

WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME
AND NET CASH PROVIDED BY OPERATING ACTIVITIES
(Unaudited)
Three Months Ended December 31, Three Months Ended March 31,
202520262025
(In thousands of dollars)
Net cash provided by operating activities$120,379 $110,198 $45,781 
Changes in operating assets and liabilities and other(36,121)(28,543)(3,472)
Net income84,258 81,655 42,309 
Add:
Depreciation, amortization and disposition of property, plant and equipment35,029 34,360 27,171 
Less:
Contribution to turnaround reserves(10,513)(10,232)(7,622)
Maintenance capital expenditures(5,848)(7,810)(20,577)
Distributable cash flow attributable to noncontrolling interest in OpCo(84,135)(80,087)(36,567)
MLP distributable cash flow$18,791 $17,886 $4,714 

vii
WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH
PROVIDED BY OPERATING ACTIVITIES
(Unaudited)
Three Months Ended December 31, Three Months Ended March 31,
202520262025
(In thousands of dollars)
Net cash provided by operating activities$120,379 $110,198 $45,781 
Changes in operating assets and liabilities and other(36,121)(28,543)(3,472)
Net income84,258 81,655 42,309 
Less:
Other income, net200 348 1,346 
Interest expense—Westlake(5,508)(5,085)(5,537)
Provision for income taxes(193)(177)(107)
Income from operations89,759 86,569 46,607 
Add:
Depreciation and amortization34,554 34,299 27,068 
Other income, net200 348 1,346 
EBITDA$124,513 $121,216 $75,021 

viii

Source: View Original Filing on SEC EDGAR

FAQ

How did Westlake Chemical Partners (WLKP) perform in Q1 2026?

Westlake Chemical Partners reported net income attributable to the Partnership of $14.2 million in Q1 2026, up from $4.9 million a year earlier. Operating cash flow increased to $110.2 million from $45.8 million, reflecting higher production and sales volume after the prior year's Petro 1 turnaround.

What distribution did Westlake Chemical Partners (WLKP) declare for Q1 2026?

The Partnership declared a quarterly distribution of $0.4714 per common unit for Q1 2026, payable June 1, 2026 to unitholders of record May 14, 2026. This represents the 47th consecutive quarterly distribution since the IPO and was supported by a 1.08x coverage ratio for the quarter.

How did MLP distributable cash flow change for Westlake Chemical Partners (WLKP)?

MLP distributable cash flow increased to $17.9 million in Q1 2026 from $4.7 million in Q1 2025. Management linked this rise to higher production and sales volume and lower maintenance capital expenditures following the prior year’s Petro 1 turnaround, improving trailing twelve‑month coverage to 1.00x.

What impact did geopolitical events have on Westlake Chemical Partners (WLKP)?

Management stated that late in Q1 2026, the war with Iran and closure of the Strait of Hormuz accelerated global demand for North American chemicals and polymers. This surge increased third‑party ethylene sales prices, which the Partnership indicated is benefiting distributable cash flow and the coverage ratio.

What were Westlake Chemical Partners’ (WLKP) key revenue and EBITDA figures for Q1 2026?

Total net sales were $305.7 million in Q1 2026, up from $237.6 million in Q1 2025. Revenue from Westlake Corporation reached $263.1 million, while EBITDA was $121.2 million compared with $75.0 million in the prior‑year quarter, highlighting stronger operating performance.

How stable are Westlake Chemical Partners’ (WLKP) cash flows under its ethylene sales agreement?

The Partnership noted that OpCo’s Ethylene Sales Agreement with Westlake is designed to provide stable, predictable cash flows. It specifies that 95% of OpCo’s ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of costs and turnaround reserves.

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents